Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) EVP Steve Weinrauch sold 6,674 shares of the company’s stock in a transaction that occurred on Friday, June 5th. The shares were sold at an average price of $22.00, for a total value of $146,828.00. Following the completion of the transaction, the executive vice president owned 78,062 shares in the company, valued at approximately $1,717,364. The trade was a 7.88% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.
Trupanion Price Performance
Trupanion stock opened at $23.38 on Thursday. Trupanion, Inc. has a 12 month low of $21.16 and a 12 month high of $57.88. The company has a current ratio of 1.73, a quick ratio of 1.73 and a debt-to-equity ratio of 0.25. The business’s 50 day simple moving average is $24.34 and its 200 day simple moving average is $29.42. The company has a market cap of $1.02 billion, a price-to-earnings ratio of 39.63 and a beta of 1.45.
Trupanion (NASDAQ:TRUP – Get Free Report) last posted its quarterly earnings data on Thursday, April 30th. The financial services provider reported $0.11 EPS for the quarter, beating the consensus estimate of $0.07 by $0.04. Trupanion had a return on equity of 6.87% and a net margin of 1.74%.The business had revenue of $384.05 million for the quarter, compared to the consensus estimate of $379.77 million. During the same quarter in the prior year, the business earned ($0.03) earnings per share. Trupanion’s revenue for the quarter was up 12.3% on a year-over-year basis. Sell-side analysts forecast that Trupanion, Inc. will post 0.53 EPS for the current year.
Hedge Funds Weigh In On Trupanion
Analysts Set New Price Targets
A number of equities research analysts have issued reports on TRUP shares. Piper Sandler lowered their target price on shares of Trupanion from $60.00 to $45.00 and set an “overweight” rating on the stock in a report on Friday, February 13th. Stifel Nicolaus reduced their price target on Trupanion from $35.00 to $31.00 and set a “hold” rating for the company in a research report on Tuesday, March 31st. Cantor Fitzgerald reduced their price target on Trupanion from $42.00 to $34.00 and set a “neutral” rating for the company in a research report on Thursday, April 9th. Bank of America reduced their price target on Trupanion from $63.00 to $59.00 and set a “buy” rating for the company in a research report on Tuesday, April 14th. Finally, Weiss Ratings reiterated a “sell (d+)” rating on shares of Trupanion in a research report on Monday, June 1st. Two research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $42.25.
Check Out Our Latest Stock Analysis on TRUP
Trupanion Company Profile
Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.
Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.
Featured Stories
- Five stocks we like better than Trupanion
- Everpure: AI Storage Uncertainty Overshadows Breakneck Growth
- This Tech ETF Is Beating QQQ—and Canada May Be Part of the Reason
- Intel Is the Market’s Most Mispriced AI Hedge
- The Biggest Opportunity From SpaceX’s IPO May Surprise You
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
